Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.33 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.33 |
| ▸ | MRGPRX2 | Q96LB1 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | HRH2 | P25021 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27625706 | 0.82 | KCNH2 (0.33) | ALDH1A1KCNH2OPRM1OPRD1MRGPRX2 | |
| SCHEMBL31410659 | 0.80 | ALOX15 (0.31) | KCNH2OPRM1OPRD1MRGPRX2CHRM3 | |
| SCHEMBL27705889 | 0.79 | TSHR (0.31) | TSHR | |
| SCHEMBL21847351 | 0.77 | GAA (0.37) | TSHRALDH1A1 | |
| SCHEMBL14087276 | 0.77 | ALDH1A1 (0.37) | TSHRALDH1A1 | |
| SCHEMBL1107364 | 0.72 | ALDH1A1 (0.35) | ALDH1A1KCNH2OPRM1OPRD1MRGPRX2 | |
| SCHEMBL21847370 | 0.71 | ALDH1A1 (0.36) | TSHRALDH1A1 | |
| SCHEMBL21847338 | 0.70 | — | — | |
| SCHEMBL5690441 | 0.69 | NAAA (0.33) | TSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL10546688 | 0.69 | ALDH1A1 (0.36) | ALDH1A1KCNH2OPRM1OPRD1MRGPRX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12291690-B2 | Ethers and esters of tertiary alkanols for use as aroma chemicals | BASF SE (DE) | 2025-05-06 | — | — | US | disclosed |
| EP-3867217-B1 | ETHERS AND ESTERS OF TERTIARY ALKANOLS FOR USE AS AROMA CHEMICALS | BASF SE (DE) | 2022-12-07 | — | — | EP | disclosed |
| US-20210388288-A1 | ETHERS AND ESTERS OF TERTIARY ALKANOLS FOR USE AS AROMA CHEMICALS | BASF SE (DE) | 2021-12-16 | — | — | US | disclosed |
| WO-2020079011-A1 | ETHERS AND ESTERS OF TERTIARY ALKANOLS FOR USE AS AROMA CHEMICALS | BASF SE (DE) | 2020-04-23 | — | — | WO | disclosed |
| EP-3640233-A1 | ETHERS AND ESTERS OF TERTIARY ALKANOLS FOR USE AS AROMA CHEMICALS | BASF SE (DE) | 2020-04-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210388288-A1 | ETHERS AND ESTERS OF TERTIARY ALKANOLS FOR USE AS AROMA CHEMICALS | OR51E2, ETV1, ALK | TSHR 3071/4885ALDH1A1 71/4885KCNH2 1275/4885 |
| US-12291690-B2 | Ethers and esters of tertiary alkanols for use as aroma chemicals | OR51E2, ETV1, ALK | TSHR 3071/4885ALDH1A1 71/4885KCNH2 1275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.